These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 89282)

  • 1. Evidence for raised K-cell levels in type-I diabetes.
    Pozzilli P; Sensi M; Gorsuch A; Bottazzo GF; Cudworth AG
    Lancet; 1979 Jul; 2(8135):173-5. PubMed ID: 89282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.
    Bottazzo GF; Florin-Christensen A; Doniach D
    Lancet; 1974 Nov; 2(7892):1279-83. PubMed ID: 4139522
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for a primary autoimmune type of diabetes mellitus.
    Bottazzo GF; Cudworth AG; Moul DJ; Doniach D; Festenstein H
    Br Med J; 1978 Nov; 2(6147):1253-5. PubMed ID: 361163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various immunologic indices of children and adolescents with type I diabetes mellitus].
    Uriarté A; Vera M; Kabrera E; Ventura R
    Probl Endokrinol (Mosk); 1987; 33(2):22-5. PubMed ID: 2955399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens, cytoplasmic islet cell antibodies, and carbohydrate tolerance in families of children with insulin-dependent diabetes mellitus.
    Ginsberg-Fellner F; Dobersen MJ; Witt ME; Rayfield EJ; Rubinstein P; Notkins AL
    Diabetes; 1982 Apr; 31(4 Pt 1):292-8. PubMed ID: 6759245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet changes suggesting a possible immune aetiology of human diabetes mellitus.
    Gepts W
    Acta Endocrinol Suppl (Copenh); 1976; 205():95-106. PubMed ID: 793281
    [No Abstract]   [Full Text] [Related]  

  • 7. Islet cell surface antibodies in Graves' disease; as organ non-specific antibodies.
    Ahn IM; Izumi M; Nagataki S
    Korean J Intern Med; 1988 Jan; 3(1):38-44. PubMed ID: 3153792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic islet-cell antibody as a marker for asymptomatic and latent diabetes and prediabetes.
    Irvine WJ; Gray RS; McCallum CJ
    Lancet; 1976 Nov; 2(7995):1097-102. PubMed ID: 62945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cell-mediated cytotoxicity of mononuclear cells against Langerhans islets of Wistar rats in normal man and in patients at diabetes risk.
    Köhler E; Knospe S; Woltanski G; Maciejewski R; Salzsieder C; Rjasanowski I; Strese J; Michaelis D
    Biomed Biochim Acta; 1984; 43(5):627-33. PubMed ID: 6383366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that type I diabetes and thyrogastric autoimmunity have different genetic determinants.
    Gorsuch AN; Dean BM; Bottazzo GF; Lister J; Cudworth AG
    Br Med J; 1980 Jan; 280(6208):145-7. PubMed ID: 6766770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoadherence of lymphocytes from type I diabetic subjects to insulin-secreting cells. Marker of anti-beta-cell cellular immunity.
    Lang F; Maugendre D; Houssaint E; Charbonnel B; Sai P
    Diabetes; 1987 Dec; 36(12):1356-64. PubMed ID: 3315784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.
    Roura-Mir IC; Alcalde L; Vargas F; Tolosa E; Obiols G; Foz M; Jaraquemada D; Pujol-Borrell R
    Clin Exp Immunol; 1993 May; 92(2):288-95. PubMed ID: 8485915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.
    Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles MA
    Diabetologia; 1986 Jun; 29(6):352-7. PubMed ID: 3527835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in diabetes mellitus.
    Bergamaschini L; Gardinali M; Poli M; Lorini R; Bosi E; Agostoni A
    J Clin Lab Immunol; 1991 Jul; 35(3):121-7. PubMed ID: 1688167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and pancreatic islet cell antibodies in diabetes.
    Morris PJ; Irvine WJ; Gray RS; Duncan LJ; Vaughan H; McCallum FJ; Campbell CJ; Farquhar JW
    Lancet; 1976 Sep; 2(7987):652-3. PubMed ID: 60516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased killer cell activity in insulin dependent (type 1) diabetes mellitus.
    Sensi M; Pozzilli P; Gorsuch AN; Bottazzo GF; Cudworth AG
    Diabetologia; 1981 Feb; 20(2):106-9. PubMed ID: 7202884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of allogeneic lymphocyte E-rosettes induced by sera from newly diagnosed type I diabetics.
    Pozzilli P; Di Mario U; Javicoli M; Menzinger G; Andreani D
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):49-53. PubMed ID: 6986737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral autoimmunity in diabetic patients].
    Pouplard A; Bottazzo GF; Doniach D
    Nouv Presse Med; 1977 Jan; 6(4):269-72. PubMed ID: 189288
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro relationship of CD4 cells from type I diabetic patients and xenogeneic beta-cell membranes.
    Segain JP; Valentin A; Bardet S; Feve B; Sevestre H; Houssaint E; Charbonnel B; Sai P
    Diabetes; 1989 May; 38(5):634-40. PubMed ID: 2653934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.